GlobalData analysed the number of clinical trials of both industry and non-industry-sponsored trials with start dates between January 2019 and December 2019.

GlobalData analysed trials with industry and non-industry sponsors. Figure 1 shows that overall non-industry sponsors conducted more trials than industry sponsors in 2019. Industry sponsors conducted the highest percentage of trials in Q4 at 46.9%, whereas non-industry sponsors had the highest percentage of trials in Q1 at 67.6%.

After further analysis, Novartis had conducted the highest amount of trials in 2019 for an industry sponsor, whereas Cairo University had conducted the most amount of trials for a non-industry sponsor. Industry-sponsored trials were the lowest in Q3 at 32.9% and non-industry-sponsored trials were the lowest in Q4 at 53.1%. Overall the US had conducted the highest amount of trials for 2019, followed by China.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.